Design and Synthesis of Pleuromutilin Derivatives as Antibacterial Agents Using Quantitative Structure–Activity Relationship Model

Jiaming Zhang,Qinqin Liu,Haoxia Zhao,Guiyu Li,Yunpeng Yi,Ruofeng Shang

DOI: https://doi.org/10.3390/ijms25042256

IF: 5.6

2024-02-14

International Journal of Molecular Sciences

Abstract:The quantitative structure–activity relationship (QSAR) is one of the most popular methods for the virtual screening of new drug leads and optimization. Herein, we collected a dataset of 955 MIC values of pleuromutilin derivatives to construct a 2D-QSAR model with an accuracy of 80% and a 3D-QSAR model with a non-cross-validated correlation coefficient (r2) of 0.9836 and a cross-validated correlation coefficient (q2) of 0.7986. Based on the obtained QSAR models, we designed and synthesized pleuromutilin compounds 1 and 2 with thiol-functionalized side chains. Compound 1 displayed the highest antimicrobial activity against both Staphylococcus aureus ATCC 29213 (S. aureus) and Methicillin-resistant Staphylococcus aureus (MRSA), with minimum inhibitory concentrations (MICs) < 0.0625 μg/mL. These experimental results confirmed that the 2D and 3D-QSAR models displayed a high accuracy of the prediction function for the discovery of lead compounds from pleuromutilin derivatives.

biochemistry & molecular biology,chemistry, multidisciplinary

What problem does this paper attempt to address?

The problem this paper attempts to address is the development of new antibacterial agents to combat resistant strains, particularly Staphylococcus aureus (S. aureus) and its methicillin-resistant variant (Methicillin-resistant Staphylococcus aureus, MRSA). To achieve this goal, researchers utilized Quantitative Structure–Activity Relationship (QSAR) models to design and synthesize new pleuromutilin derivatives. Specifically, they constructed 2D-QSAR and 3D-QSAR models and based on these models, designed two new compounds containing thiol-functionalized side chains (Compound 1 and Compound 2), and tested the antibacterial activity of these compounds in vitro. The results showed that Compound 1 exhibited extremely high inhibitory effects against MRSA and S. aureus ATCC 29213, with a minimum inhibitory concentration (MIC) of less than 0.0625 µg/mL, indicating that the compounds designed through QSAR models have significant antibacterial effects. Additionally, molecular docking studies further validated the binding modes of these compounds with the ribosomal peptidyl transferase center (PTC) domain, thereby explaining their antibacterial mechanism.

Design and Synthesis of Pleuromutilin Derivatives as Antibacterial Agents Using Quantitative Structure–Activity Relationship Model

Quantitative Structure–activity Relationship: Promising Advances in Drug Discovery Platforms

Design, synthesis, biological evaluation and molecular docking study of novel pleuromutilin derivatives containing substituted benzoxazole as antibacterial agents

Synthesis and antibacterial activity of novel icariin derivatives.

Antibacterial activity evaluation of pleuromutilin derivatives with 4(3 H )-quinazolinone scaffold against methicillin-resistant Staphylococcus aureus

Design, Synthesis, Antibacterial Activity Evaluation and Molecular Docking Study of Pleuromutilin Derivatives Bearing Amide Side Chains

Design, Synthesis and Antibacterial Evaluation of Pleuromutilin Derivatives

Design, Synthesis, in Vitro and in Vivo Evaluation and Molecular Docking Study of Novel Pleuromutilin Derivatives As Antibacterial Agents

Design, synthesis, biological evaluation and molecular docking studies of novel pleuromutilin derivatives containing nitrogen heterocycle and alkylamine groups

Design, synthesis, and antibacterial activity of pleuromutilin derivatives

QSAR and molecular design of some quinoline derivatives as antimicrobial

Design, synthesis, in vitro and in vivo evaluation against MRSA and molecular docking studies of novel pleuromutilin derivatives bearing 1, 3, 4-oxadiazole linker

Synthesis And Biological Evaluation Of New Pleuromutilin Derivatives As Antibacterial Agents

Design, synthesis and antibacterial activity evaluation of pleuromutilin derivatives according to twin drug theory

Discovery of novel pleuromutilin derivatives as potent antibacterial agents

Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety

Design, Synthesis and Biological Evaluation of Novel Pleuromutilin Derivatives Containing 6-Chloro-1-R-1H-pyrazolo[3,4-d]pyrimidine-4-amino Side Chain

Design, synthesis and biological evaluation of novel pleuromutilin derivatives as potent anti-MRSA agents targeting the 50S ribosome

Synthesis and Antibacterial Activities of Pleuromutilin Derivatives with Quinazolinone and Thioether Groups

Design, synthesis and biological evaluation of novel pleuromutilin derivatives possessing 4-aminothiophenol linker as promising antibacterial agents

Novel Sulfonylurea Derivatives as Potential Antimicrobial Agents: Chemical Synthesis, Biological Evaluation, and Computational Study